Synthesis of surface glycoproteins and glycosphingolipids in db-cAMP-treated normal and virus-transformed 3T3 cells.
D000818:Animals; D003994:Bucladesine / Q000494:pharmacology*; D002250:Carbon Radioisotopes; D002455:Cell Division / Q000187:drug effects; D002462:Cell Membrane / Q000187:drug effects / Q000378:metabolism; D002471:Cell Transformation, Neoplastic / Q000187:drug effects; D002478:Cells, Cultured; D002848:Chromatography, DEAE-Cellulose; D002855:Chromatography, Thin Layer; D005347:Fibroblasts / Q000187:drug effects / Q000378:metabolism; D005690:Galactose / Q000378:metabolism; D005944:Glucosamine / Q000378:metabolism; D006017:Glycolipids / Q000096:biosynthesis*; D006023:Glycoproteins / Q000096:biosynthesis*; D007700:Kinetics; D051379:Mice; D013107:Sphingolipids / Q000096:biosynthesis*; D013806:Theophylline / Q000494:pharmacology; D013997:Time Factors
D002250:Carbon Radioisotopes; D006017:Glycolipids; D006023:Glycoproteins; D013107:Sphingolipids; D003994:Bucladesine; D013806:Theophylline; D005944:Glucosamine; D005690:Galactose